LORI DOYLE: Open Payments
NPI 1558753293 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 33 payments from 12 companies in 2025. Trend: 2023 $1,308 · 2024 $596 · 2025 $674
Food & beverage: $602Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $250 |
| ABBVIE INC. | 4 | $79 |
| UCB, Inc. | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
| Lilly USA, LLC | 3 | $49 |
| Amgen Inc. | 2 | $42 |
| Arcutis Biotherapeutics, Inc. | 2 | $34 |
| Almirall LLC | 1 | $25 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: TREMFYA, SKYRIZI, Bimzelx, DUPIXENT, TALTZ, OTEZLA, Zoryve, Seysara.
Industry payments across VA — which companies pay providers there.
